Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


1 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 Antivir Ther
1 Br J Dermatol
1 Cancer
1 Drugs
1 Int J Dermatol
7 J Acquir Immune Defic Syndr
1 J Clin Oncol
1 J Immunol
5 J Infect Dis
1 J Med Virol
1 J Virol
1 Lancet HIV
1 Lancet Infect Dis
1 Nature
1 Pediatr Infect Dis J
15 PLoS One
5 PLoS Pathog
2 Vaccine

    AIDS Res Hum Retroviruses

  1. LU X, Li Y, Wang Y, An N, et al
    Regional transmission pattern of HIV-1 Non-CRF01_AE strains circulating in Hebei province, China.
    AIDS Res Hum Retroviruses. 2017 Sep 25. doi: 10.1089/AID.2017.0166.
    >> Share

    Antimicrob Agents Chemother

  2. ELOY P, Tessier A, Fan-Havard P, Chou M, et al
    Genetics of nevirapine metabolic pathways at steady state in HIV-infected Cambodians.
    Antimicrob Agents Chemother. 2017 Sep 25. pii: AAC.00733.
    >> Share

    Antivir Ther

  3. SANTORO MM, Di Carlo D, Armenia D, Zaccarelli M, et al
    Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice.
    Antivir Ther. 2017 Sep 22. doi: 10.3851/IMP3197.
    >> Share


  4. MISTRY VN, Suida MI, Kirkham D, Ho MWS, et al
    An atypical, non-healing perioral lesion.
    BMJ. 2017;358:j3823.
    >> Share

    One in six people newly diagnosed with HIV in Europe is now aged over 50.
    BMJ. 2017;358:j4456.
    >> Share

    Br J Dermatol

  6. QU H, Zhao Z, Yu J
    Image Gallery: Cutaneous presentation of disseminated cryptococcosis in a patient with undiagnosed HIV infection.
    Br J Dermatol. 2017;177:e73.
    >> Share


  7. DESHMUKH AA, Chiao EY, Cantor SB, Stier EA, et al
    Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.31035.
    >> Share


    Elsulfavirine: First Global Approval.
    Drugs. 2017 Sep 23. doi: 10.1007/s40265-017-0820.
    >> Share

    Int J Dermatol

  9. BOUSHAB BM, Malick Fall FZ, Ould Cheikh Mohamed Vadel TK, Ould Cheikh Melainine ML, et al
    Mucocutaneous manifestations in human immunodeficiency virus (HIV)-infected patients in Nouakchott, Mauritania.
    Int J Dermatol. 2017 Sep 27. doi: 10.1111/ijd.13737.
    >> Share

    J Acquir Immune Defic Syndr

  10. CATTANEO D, Minisci D, Baldelli S, Mazzali C, et al
    Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001558.
    >> Share

  11. DORWARD J, Mabuto T, Charalambous S, Fielding KL, et al
    Factors associated with poor linkage to HIV care in South Africa: secondary analysis of data from the Thol'impilo trial.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001550.
    >> Share

  12. HABERER JE, Ngure K, Muwonge T, Mugo N, et al
    Context matters: PrEP adherence is associated with sexual behavior among HIV serodiscordant couples in East Africa.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001548.
    >> Share

  13. BALKUS JE, Brown ER, Palanee-Phillips T, Kiweewa FM, et al
    Performance of a validated risk score to predict HIV-1 acquisition among African women participating in a trial of the dapivirine vaginal ring.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001556.
    >> Share

  14. LEVASSEUR MT, Goldstein ND, Tabb LP, Olivieri-Mui BL, et al
    The Effect of PrEP on HIV Incidence Among Men Who Have Sex With Men in the Context of Condom Use, Treatment as Prevention, and Seroadaptive Practices.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001555.
    >> Share

  15. ANZINGER JJ, Butterfield TR, Gouillou M, McCune JM, et al
    Glut1 Expression Level on Inflammatory Monocytes is Associated with Markers of Cardiovascular Disease Risk in HIV-Infected Individuals.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001559.
    >> Share

  16. INZAULE SC, Osi SJ, Akinbiyi G, Emeka A, et al
    High prevalence of HIV drug resistance among newly diagnosed infants aged <18 months: results from a nationwide surveillance in Nigeria.
    J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001553.
    >> Share

    J Clin Oncol

  17. SAUNDERS CL, Meads C, Abel GA, Lyratzopoulos G, et al
    Associations Between Sexual Orientation and Overall and Site-Specific Diagnosis of Cancer: Evidence From Two National Patient Surveys in England.
    J Clin Oncol. 2017 Sep 25:JCO2017725465. doi: 10.1200/JCO.2017.72.5465.
    >> Share

    J Immunol

  18. LIU F, Niu Q, Fan X, Liu C, et al
    Priming and Activation of Inflammasome by Canarypox Virus Vector ALVAC via the cGAS/IFI16-STING-Type I IFN Pathway and AIM2 Sensor.
    J Immunol. 2017 Sep 25. pii: ji1700698. doi: 10.4049/jimmunol.1700698.
    >> Share

    J Infect Dis

  19. MOORE T, Dembry LM, Saag MS
    Sunday in the Park with Infectious Disease: Workforce Mismatch in a Colorful Universe of Possibilities.
    J Infect Dis. 2017;216.
    >> Share

  20. DEL RIO C
    From Trained Infectious Diseases Clinician to Global Health Leader, Reflections on the Last 30 Years.
    J Infect Dis. 2017;216.
    >> Share

    Life as an Infectious Diseases Physician Scientist: Science is Humanity's Lifeline.
    J Infect Dis. 2017;216.
    >> Share

    Human Immunodeficiency Virus Medicine.
    J Infect Dis. 2017;216.
    >> Share

  23. CRABTREE KL, Wojcicki JM, Minhas V, Kankasa C, et al
    Food and Drink Sharing in the Household are Associated with HHV-8 Seroconversion in a Cohort of Zambian Children.
    J Infect Dis. 2017 Aug 14. doi: 10.1093.
    >> Share

    J Med Virol

  24. RAHMAN M, Hossain ME, Afrad MH, Hasan R, et al
    Hepatitis C Virus infections among clients attending an HIV testing and counseling center in Dhaka, Bangladesh.
    J Med Virol. 2017 Sep 28. doi: 10.1002/jmv.24955.
    >> Share

    J Virol

  25. MARRAS F, Casabianca A, Bozzano F, Ascierto ML, et al
    Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.
    J Virol. 2017 Sep 27. pii: JVI.00647-17. doi: 10.1128/JVI.00647.
    >> Share

    Lancet HIV

    Would you like an HIV test?
    Lancet HIV. 2017;4:e423.
    >> Share

    Lancet Infect Dis

  27. BEIGEL JH, Bao Y, Beeler J, Manosuthi W, et al
    Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.
    Lancet Infect Dis. 2017 Sep 22. pii: S1473-3099(17)30476.
    >> Share


  28. TAKATA MA, Goncalves-Carneiro D, Zang TM, Soll SJ, et al
    CG dinucleotide suppression enables antiviral defence targeting non-self RNA.
    Nature. 2017 Sep 27. doi: 10.1038/nature24039.
    >> Share

    Pediatr Infect Dis J

  29. ARYA BK, Bhattacharya SD, Sutcliffe CG, Ganaie F, et al
    Nasopharyngeal pneumococcal colonization and impact of a single dose of 13-valent pneumococcal conjugate vaccine in Indian children with HIV and their unvaccinated parents.
    Pediatr Infect Dis J. 2017 Sep 27. doi: 10.1097/INF.0000000000001800.
    >> Share

    PLoS One

  30. ROSAS-UMBERT M, Mothe B, Noguera-Julian M, Bellido R, et al
    Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.
    PLoS One. 2017;12:e0184929.
    >> Share

  31. ROCHELEAU G, Franco-Villalobos C, Oliveira N, Brumme ZL, et al
    Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada.
    PLoS One. 2017;12:e0184848.
    >> Share

  32. JACKSON E, Zhang CX, Kiani Z, Lisovsky I, et al
    HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness.
    PLoS One. 2017;12:e0185160.
    >> Share

  33. LARSON EC, Novis CL, Martins LJ, Macedo AB, et al
    Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro.
    PLoS One. 2017;12:e0185162.
    >> Share

  34. DANYUTTAPOLCHAI J, Kittimunkong S, Nateniyom S, Painujit S, et al
    Implementing an isoniazid preventive therapy program for people living with HIV in Thailand.
    PLoS One. 2017;12:e0184986.
    >> Share

  35. VACCHER SJ, Grulich AE, Haire BG, Conway DP, et al
    Validation of participant eligibility for pre-exposure prophylaxis: Baseline data from the PRELUDE demonstration project.
    PLoS One. 2017;12:e0185398.
    >> Share

  36. GARCIA M, Harris AL
    PrEP awareness and decision-making for Latino MSM in San Antonio, Texas.
    PLoS One. 2017;12:e0184014.
    >> Share

  37. PESSOA R, Sanabani SS
    High prevalence of HIV-1 transmitted drug-resistance mutations from proviral DNA massively parallel sequencing data of therapy-naive chronically infected Brazilian blood donors.
    PLoS One. 2017;12:e0185559.
    >> Share

  38. REBNORD T, Ostbye T, Mmbaga BT, Mchome B, et al
    Time trends in management of HIV-positive pregnant women in Northern Tanzania: A registry-based study.
    PLoS One. 2017;12:e0184362.
    >> Share

  39. ROSS-DEGNAN D, Chalker J, Liana J, Kajoka MD, et al
    A group randomized trial using an appointment system to improve adherence to ART at reproductive and child health clinics implementing Option B+ in Tanzania.
    PLoS One. 2017;12:e0184591.
    >> Share

  40. TAVARES AM, Fronteira I, Couto I, Machado D, et al
    HIV and tuberculosis co-infection among migrants in Europe: A systematic review on the prevalence, incidence and mortality.
    PLoS One. 2017;12:e0185526.
    >> Share

  41. LOUTFY M, de Pokomandy A, Kennedy VL, Carter A, et al
    Cohort profile: The Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS).
    PLoS One. 2017;12:e0184708.
    >> Share

  42. MURRAY KR, Dulli LS, Ridgeway K, Dal Santo L, et al
    Improving retention in HIV care among adolescents and adults in low- and middle-income countries: A systematic review of the literature.
    PLoS One. 2017;12:e0184879.
    >> Share

  43. PEREZ-LOSADA M, Castel AD, Lewis B, Kharfen M, et al
    Characterization of HIV diversity, phylodynamics and drug resistance in Washington, DC.
    PLoS One. 2017;12:e0185644.
    >> Share

  44. CHUCHUEN O, Maher JR, Henderson MH, Desoto M, et al
    Label-free analysis of tenofovir delivery to vaginal tissue using co-registered confocal Raman spectroscopy and optical coherence tomography.
    PLoS One. 2017;12:e0185633.
    >> Share

    PLoS Pathog

  45. DEL PRETE GQ, Keele BF, Fode J, Thumar K, et al
    A single gp120 residue can affect HIV-1 tropism in macaques.
    PLoS Pathog. 2017;13:e1006572.
    >> Share

  46. RADEMEYER C, Korber B, Seaman MS, Giorgi EE, et al
    Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
    PLoS Pathog. 2017;13:e1006641.
    >> Share

  47. OBENG-ADJEI N, Portugal S, Holla P, Li S, et al
    Malaria-induced interferon-gamma drives the expansion of Tbethi atypical memory B cells.
    PLoS Pathog. 2017;13:e1006576.
    >> Share

  48. TARTOUR K, Nguyen XN, Appourchaux R, Assil S, et al
    Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.
    PLoS Pathog. 2017;13:e1006610.
    >> Share

  49. ABERE B, Mamo TM, Hartmann S, Samarina N, et al
    The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target.
    PLoS Pathog. 2017;13:e1006639.
    >> Share


  50. CHENG L, Zhang Z, Li G, Li F, et al
    Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31300.
    >> Share

  51. SCHIFFER JT, Gottlieb SL
    Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31273.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016